Literature DB >> 17934326

Predictors of survival in dementia with lewy bodies and Parkinson dementia.

Kurt A Jellinger1, Gregor K Wenning, Klaus Seppi.   

Abstract

Retrospective analysis of 243 autopsy-confirmed cases of dementia with Lewy bodies (DLB) and Parkinson disease with dementia (PDD) showed an average age at symptom onset of 67 years and a median survival of 5 years from symptom onset. Older age at onset, fluctuating cognition, and hallucinations at onset predicted shorter survival; initial parkinsonism with delayed dementia significantly improved survival. Associated Alzheimer pathology also shortened survival. When adjusted for age, gender, and Alzheimer pathology, fluctuating dementia at symptom onset was identified as best predictor of poor outcome. Copyright (c) 2007 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2007        PMID: 17934326     DOI: 10.1159/000107703

Source DB:  PubMed          Journal:  Neurodegener Dis        ISSN: 1660-2854            Impact factor:   2.977


  27 in total

1.  Dementia with lewy bodies: diagnosis and management for primary care providers.

Authors:  Melanie Zupancic; Aman Mahajan; Kamna Handa
Journal:  Prim Care Companion CNS Disord       Date:  2011

2.  Survival and Causes of Death Among People With Clinically Diagnosed Synucleinopathies With Parkinsonism: A Population-Based Study.

Authors:  Rodolfo Savica; Brandon R Grossardt; James H Bower; J Eric Ahlskog; Bradley F Boeve; Jonathan Graff-Radford; Walter A Rocca; Michelle M Mielke
Journal:  JAMA Neurol       Date:  2017-07-01       Impact factor: 18.302

3.  Pathologic accumulation of α-synuclein and Aβ in Parkinson disease patients with dementia.

Authors:  Paul T Kotzbauer; Nigel J Cairns; Meghan C Campbell; Allison W Willis; Brad A Racette; Samer D Tabbal; Joel S Perlmutter
Journal:  Arch Neurol       Date:  2012-10

4.  Pattern of brain atrophy rates in autopsy-confirmed dementia with Lewy bodies.

Authors:  Zuzana Nedelska; Tanis J Ferman; Bradley F Boeve; Scott A Przybelski; Timothy G Lesnick; Melissa E Murray; Jeffrey L Gunter; Matthew L Senjem; Prashanti Vemuri; Glenn E Smith; Yonas E Geda; Jonathan Graff-Radford; David S Knopman; Ronald C Petersen; Joseph E Parisi; Dennis W Dickson; Clifford R Jack; Kejal Kantarci
Journal:  Neurobiol Aging       Date:  2014-07-15       Impact factor: 4.673

5.  Factors affecting survival of patients with neurodegenerative disease.

Authors:  Kyle Steenland; Jessica MacNeil; Ryan Seals; Allan Levey
Journal:  Neuroepidemiology       Date:  2010-04-08       Impact factor: 3.282

Review 6.  Dementia with Lewy bodies and Parkinson's disease-dementia: current concepts and controversies.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2017-12-08       Impact factor: 3.575

7.  Significance of cerebral amyloid angiopathy and other co-morbidities in Lewy body diseases.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2021-04-29       Impact factor: 3.575

Review 8.  Parkinson's disease dementia: convergence of α-synuclein, tau and amyloid-β pathologies.

Authors:  David J Irwin; Virginia M-Y Lee; John Q Trojanowski
Journal:  Nat Rev Neurosci       Date:  2013-07-31       Impact factor: 34.870

9.  Principal component analysis of PiB distribution in Parkinson and Alzheimer diseases.

Authors:  Meghan C Campbell; Joanne Markham; Hubert Flores; Johanna M Hartlein; Alison M Goate; Nigel J Cairns; Tom O Videen; Joel S Perlmutter
Journal:  Neurology       Date:  2013-07-03       Impact factor: 9.910

10.  Dementia with Lewy bodies: basis of cingulate island sign.

Authors:  Jonathan Graff-Radford; Melissa E Murray; Val J Lowe; Bradley F Boeve; Tanis J Ferman; Scott A Przybelski; Timothy G Lesnick; Matthew L Senjem; Jeffrey L Gunter; Glenn E Smith; David S Knopman; Clifford R Jack; Dennis W Dickson; Ronald C Petersen; Kejal Kantarci
Journal:  Neurology       Date:  2014-07-23       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.